Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05305079 · ClinicalTrials.gov registry record
NA-AION Risk Factors: New Perspectives
A clinical trial, sponsored by Rigshospitalet, Denmark.
- Completed
- Registry status
- 179
- Enrollment target
NCT05305079 is a clinical trial that has completed, run by Rigshospitalet, Denmark. The registered enrollment target is 179 participants.
The verdict
NCT05305079 has completed, sponsored by Rigshospitalet, Denmark.
- COMPLETED
- Registry status
- 179 participants
- Enrollment target
Study Summary
The purpose of the study is to use new diagnostic methods (OCT and OCT-A) to shed light on risk factors for the development of NA-AION. The risk factors we are focusing on are comorbidities along with anatomical and vascular characteristics of the optic nerve.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2024-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05305079
The ClinicalTrials.gov registry entry for NCT05305079 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 179 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rigshospitalet, Denmark, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05305079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05305079 about?
NCT05305079 is a clinical study titled "NA-AION Risk Factors: New Perspectives". The purpose of the study is to use new diagnostic methods (OCT and OCT-A) to shed light on risk factors for the development of NA-AION. The risk factors we are focusing on are comorbidities along with anatomical and vascular characteristics of the optic nerve.
What is the current status of trial NCT05305079?
This trial is currently completed. The enrollment target is 179 participants. The study started on 2021-08-01. Estimated completion is 2024-08-31.
Who is sponsoring clinical trial NCT05305079?
This trial is sponsored by Rigshospitalet, Denmark, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.